Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification

Area of Science:

• Oncology
• Molecular Pathology
• Genetics

Background:

• Lung cancer remains a leading cause of cancer death globally.
• Late diagnoses and limited treatment options contribute to poor outcomes.
• Recent advances have elucidated comprehensive molecular profiles of lung cancer.

Purpose of the Study:

• To review recent developments in molecular profiling of lung cancer.
• To provide perspectives on updated diagnostic concepts in the 2015 WHO classification.
• To highlight the impact of molecular understanding on lung cancer classification and treatment.

Main Methods:

• Review of recent scientific literature on lung cancer molecular profiling.
• Analysis of the 2015 World Health Organization (WHO) classification of lung cancer.
• Discussion of the integration of molecular data into histopathological diagnosis.

Main Results:

• Identification of driver genetic alterations and molecular targets has enabled targeted therapies.
• Molecular profiles have significantly enhanced the understanding of lung cancer pathology.
• The 2015 WHO classification incorporates molecular insights, modifying histopathological categories.

Conclusions:

• Molecular profiling is revolutionizing lung cancer diagnosis and treatment.
• The current WHO classification requires further updates to fully integrate molecular findings.
• Continued research into molecular characteristics is essential for improved, clinically meaningful tumor diagnoses.